Cargando…

Comparative effectiveness of different hepatocellular carcinoma screening intervals or modalities: a systematic review and meta-analysis

BACKGROUND: Current guidelines recommend hepatocellular carcinoma (HCC) screening in high-risk populations. However, the ideal HCC screening interval and screening modality have not been determined. This study aimed to compare the screening efficacy among different modalities with various intervals....

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Jichun, Yang, Zhirong, Zeng, Xueyang, Yu, Shuqing, Gao, Le, Jiang, Yu, Sun, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Meta Analysis
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309520/ https://www.ncbi.nlm.nih.gov/pubmed/36921104 http://dx.doi.org/10.1097/CM9.0000000000002341

Ejemplares similares

Systematic review and meta-analysis comparing zoledronic acid administered at 12-week and 4-week intervals in patients with bone metastasis
por: Cao, Ling, et al.
Publicado: (2017)

XPD Polymorphisms and Risk of Hepatocellular Carcinoma and Gastric Cancer: A Meta-Analysis
por: Zhou, Qiang, et al.
Publicado: (2021)

What is the best combination treatment with transarterial chemoembolization of unresectable hepatocellular carcinoma? a systematic review and network meta-analysis
por: Xie, Hui, et al.
Publicado: (2017)

Prognostic value of microRNAs in hepatocellular carcinoma: a meta-analysis
por: Zhang, Yue, et al.
Publicado: (2017)

Clinicopathologic and prognostic significance of regulatory T cells in patients with hepatocellular carcinoma: a meta-analysis
por: Sun, Lejia, et al.
Publicado: (2017)

Can Statin Treatment Reduce the Risk of Hepatocellular Carcinoma? A Systematic Review and Meta-Analysis
por: Chang, Yue, et al.
Publicado: (2020)

Diagnostic value of contrast-enhanced ultrasound in hepatocellular carcinoma: a meta-analysis with evidence from 1998 to 2016
por: Zhang, Juanjuan, et al.
Publicado: (2017)

Efficacy of radiofrequency ablation versus laparoscopic liver resection for hepatocellular carcinoma in China: a comprehensive meta-analysis
por: Li, Zhijun, et al.
Publicado: (2021)

Accuracy of baseline low-dose computed tomography lung cancer screening: a systematic review and meta-analysis
por: Guo, Lanwei, et al.
Publicado: (2023)

Investigation of miR-490-3p Expression in Hepatocellular Carcinoma Based on Reverse Transcription-Polymerase Chain Reaction (RT-qPCR) and a Meta-Analysis of 749 Cases
por: Li, Ming-fen, et al.
Publicado: (2018)

MicroRNA-122 as a diagnostic biomarker for hepatocellular carcinoma related to hepatitis C virus: a meta-analysis and systematic review
por: Wei, Xiao-yu, et al.
Publicado: (2020)

Efficacy of sorafenib in patients with hepatocellular carcinoma after resection: a meta-analysis
por: Shang, Jin, et al.
Publicado: (2017)

Epigenetic basis of hepatocellular carcinoma: A network-based integrative meta-analysis
por: Bhat, Venkat, et al.
Publicado: (2018)

Is endoscopic retrograde appendicitis therapy a better modality for acute uncomplicated appendicitis? A systematic review and meta-analysis
por: Wang, Ying, et al.
Publicado: (2021)

Corrected QT interval in cirrhosis: A systematic review and meta-analysis
por: Papadopoulos, Vasileios Periklis, et al.
Publicado: (2023)

Rs3746444 T>C locus in miR-499 increases the susceptibility to hepatocellular carcinoma: A meta-analysis 14812 subjects
por: Jiang, Jia-Kai, et al.
Publicado: (2023)

Interferon-γ +874A/T Polymorphism and Hepatocellular Carcinoma Risk: A Meta-Analysis
por: Zhou, Huan, et al.
Publicado: (2015)

Prognostic Value of VEGF in Hepatocellular Carcinoma Patients Treated with Sorafenib: A Meta-Analysis
por: Cao, Guangchao, et al.
Publicado: (2015)

Prognostic value of c-Met overexpression in hepatocellular carcinoma: a meta-analysis and review
por: Kim, Jung Han, et al.
Publicado: (2017)

Prognostic and clinicopathological significance of PD-1 expression in hepatocellular carcinoma: a meta-analysis
por: Zhang, Qian, et al.
Publicado: (2020)

Repeat resection versus percutaneous ablation for recurrent hepatocellular carcinoma: a meta-analysis
por: Zhang, Feng-Qin, et al.
Publicado: (2022)

Improvement of Survival Rate for Patients with Hepatocellular Carcinoma Using Transarterial Chemoembolization in Combination with Three-Dimensional Conformal Radiation Therapy: A Meta-Analysis
por: Bai, Houqiao, et al.
Publicado: (2016)

lncRNAs as prognostic molecular biomarkers in hepatocellular carcinoma: a systematic review and meta-analysis
por: Zheng, Chuqian, et al.
Publicado: (2017)

Molecular targeted agents as second-line treatment for hepatocellular carcinoma: a meta-analysis and review
por: Kim, Jung Han, et al.
Publicado: (2017)

Immunotherapy with dendritic cells and cytokine-induced killer cells for hepatocellular carcinoma: A meta-analysis
por: Cao, Jing, et al.
Publicado: (2019)

Network meta-analysis of the prognosis of curative treatment strategies for recurrent hepatocellular carcinoma after hepatectomy
por: Chen, Jen-Lung, et al.
Publicado: (2023)

Efficacy and safety of venetoclax-based regimens for the treatment of relapsed/refractory multiple myeloma: a systemic review and meta-analysis
por: Xu, Linchun, et al.
Publicado: (2023)

Hepatocellular carcinoma recurrence in living and deceased donor liver transplantation: a systematic review and meta-analysis
por: Zhang, Hai-Ming, et al.
Publicado: (2019)

Sorafenib in the treatment of patients with hepatocellular carcinoma (HCC) and microvascular infiltration: a systematic review and meta-analysis
por: Gu, Wang, et al.
Publicado: (2020)

Abnormally expressed circular RNAs as novel non-invasive biomarkers for hepatocellular carcinoma: A meta-analysis
por: Jiang, Ya-Lin, et al.
Publicado: (2019)

Anatomical vs nonanatomical liver resection for solitary hepatocellular carcinoma: A systematic review and meta-analysis
por: Liu, Hu, et al.
Publicado: (2021)

Does size matter for resection of giant versus non-giant hepatocellular carcinoma? A meta-analysis
por: Lee, Aaron JL, et al.
Publicado: (2023)

Combining des-gamma-carboxyprothrombin and alpha-fetoprotein for hepatocellular carcinoma diagnosing: an update meta-analysis and validation study
por: Chen, Huaping, et al.
Publicado: (2017)

Dissecting novel mechanisms of hepatitis B virus related hepatocellular carcinoma using meta-analysis of public data
por: Aljabban, Jihad, et al.
Publicado: (2022)

Anterior vs conventional approach right hepatic resection for large hepatocellular carcinoma: A systematic review and meta-analysis
por: Tang, Jian-Xin, et al.
Publicado: (2017)

Circulating miRNAs as novel diagnostic biomarkers in hepatocellular carcinoma detection: a meta-analysis based on 24 articles
por: Ding, Yan, et al.
Publicado: (2017)

Transcatheter hepatic arterial chemoembolization and sorafenib for hepatocellular carcinoma: a meta-analysis of randomized, double-blind controlled trials
por: Li, Jun, et al.
Publicado: (2017)

Dose age affect the efficacy of molecular targeted agents in the treatment of hepatocellular carcinoma: a systematic review and meta-analysis
por: Du, Jing, et al.
Publicado: (2017)

Associations between hepatocellular carcinoma risk and rs3212227 and rs568408 polymorphisms: a systematic review and meta-analysis
por: Kong, Cunqing, et al.
Publicado: (2020)

Selection of first-line systemic therapies for advanced hepatocellular carcinoma: A network meta-analysis of randomized controlled trials
por: Han, Yue, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ejd15dcug1mksjm1n01pjt067o